INHIBITOR THERAPTICS INC (INTI) Total Assets by Year
INHIBITOR THERAPTICS INC closed fiscal year 2025 with $2.5M in total assets, $3.8M in total liabilities and -$1.3M in shareholder equity. This represents a decrease of 55.9% from the prior fiscal year. The table below carries 14 fiscal years, from 2012 to 2025, and the quarters INHIBITOR THERAPTICS INC has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
INTI Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY25DEF 14A | FY24DEF 14A | FY23DEF 14A | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K | FY1410-K | FY1310-K | FY1210-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $2.5M-55.9% | $5.7M-36.4% | $8.9M-25.3% | $12.0M+20271.4% | $59K-55.4% | $132K-85.4% | $900K-27.0% | $1.2M+60.5% | $768K-89.5% | $7.3M+728.4% | $886K+91.3% | $463K+4431.4% | $10K-98.9% | $936K |
| Total Liabilities | $3.8M+2.5% | $3.7M+1.2% | $3.7M-0.4% | $3.7M0.0% | $3.7M+5.4% | $3.5M+1.8% | $3.4M+185.8% | $1.2M+99.6% | $601K+95.2% | $308K-33.3% | $462K+15.2% | $401K-48.3% | $776K-27.4% | $1.1M |
| Total Equity | -$1.3M-165.1% | $2.0M-62.4% | $5.3M-36.3% | $8.3M+329.1% | -$3.6M-7.8% | -$3.4M-32.8% | -$2.5M-7924.0% | $32K-80.6% | $167K-97.6% | $7.0M+1558.1% | $424K+583.0% | $62K+108.1% | -$766K-476.8% | -$133K |
INTI Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K | Q3'2310-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $637K-83.7% | $1.4M-68.2% | $2.5M-55.9% | $3.1M-51.4% | $3.9M-45.5% | $4.5M-42.2% | $5.7M-36.4% | $6.5M-32.9% | $7.2M-29.4% | $7.8M-28.1% | $8.9M-25.3% | $9.6M+15122.0% |
| Total Liabilities | $3.2M+0.1% | $3.4M+8.2% | $3.8M+2.5% | $3.1M+2.9% | $3.2M+5.2% | $3.2M-0.1% | $3.7M+1.2% | $3.0M-3.5% | $3.0M-0.3% | $3.2M+2.5% | $3.7M-0.4% | $3.2M-22.8% |
| Total Equity | -$2.6M-457.6% | -$2.0M-246.3% | -$1.3M-165.1% | $3K-99.9% | $716K-82.7% | $1.4M-70.8% | $2.0M-62.4% | $3.4M-47.2% | $4.1M-41.8% | $4.6M-40.2% | $5.3M-36.3% | $6.5M+260.3% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More INHIBITOR THERAPTICS INC financials
Frequently Asked Questions
What was INHIBITOR THERAPTICS INC's total assets in fiscal year 2025?
INHIBITOR THERAPTICS INC closed fiscal year 2025 with $2.5M in total assets, $3.8M in total liabilities and -$1.3M in shareholder equity.
How fast is INHIBITOR THERAPTICS INC's total assets growing?
INHIBITOR THERAPTICS INC (INTI) total assets fell by 55.9% year over year, from $5.7M to $2.5M in fiscal year 2025.
How has INHIBITOR THERAPTICS INC's total assets changed over the years?
Across the 14 fiscal years this page covers, INHIBITOR THERAPTICS INC (INTI) total assets went from $936K in fiscal year 2012 to $2.5M in fiscal year 2025.
What was INHIBITOR THERAPTICS INC's total assets in the most recent quarter?
INHIBITOR THERAPTICS INC (INTI) reported $637K in total assets in Q2 2026. This represents a decrease of 83.7% from the same quarter a year earlier.
What does total assets mean on a financial statement?
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what INHIBITOR THERAPTICS INC (INTI) reported on that line in every period on record.